Conditional Survival After Radical Cystectomy for Bladder Cancer: Evidence for a Patient Changing Risk Profile over TimeGuillaume Ploussard, Wassim Kassouf, Yair Lotan et al.|European Urology|2013Cited by 147
Accuracy of the CUETO, EORTC 2016 and EAU 2021 scoring models and risk stratification tables to predict outcomes in high–grade non-muscle-invasive urothelial bladder cancerWojciech Krajewski, Ekaterina Laukhtina, Júlia Aumatell et al.|Urologic Oncology Seminars and Original Investigations|2022Cited by 29
Unlocking the Potential of Adequate Bacillus Calmette-Guérin Immunotherapy in Very-high-risk Non–muscle-invasive Bladder Carcinoma: A Multicenter Analysis of Oncological Outcomes and Risk DynamicsJosé Daniel Subiela, F.J. Burgos Revilla, Wojciech Krajewski et al.|European Urology Oncology|2024Cited by 20
The Emerging Role of Extracranial Stereotactic Ablative Radiotherapy for Metastatic Renal Cell Carcinoma: A Systematic ReviewJennifer Le Guévelou, Thomas Zilli, Paul Sargos et al.|European Urology Focus|2022Cited by 15
Prostate Cancer Therapy Cardiotoxicity Map (PROXMAP) for Advanced Disease States: A Systematic Review and Network Meta-analysis with Bayesian Modeling of Treatment HistoriesMoez Karim Aziz, Ali Ziaolhagh, Donald A. Molony et al.|European Urology|2024Cited by 15